DICE Annual SG&A
$25.66 M
+$13.44 M+109.97%
31 December 2022
Summary:
As of February 3, 2025, DICE annual selling, general & administrative expenses is $25.66 million, with the most recent change of +$13.44 million (+109.97%) on December 31, 2022. During the last 3 years, it has risen by +$22.05 million (+611.45%).DICE Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DICE Quarterly SG&A
$11.30 M
+$3.38 M+42.73%
30 June 2023
Summary:
As of February 3, 2025, DICE quarterly selling, general & administrative expenses is $11.30 million, with the most recent change of +$3.38 million (+42.73%) on June 30, 2023. Over the past year, it has increased by +$3.88 million (+52.36%).DICE Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DICE TTM SG&A
-$813.26 M
-$104.24 M-14.70%
30 June 2023
Summary:
As of February 3, 2025, DICE TTM selling, general & administrative expenses is -$813.26 million, with the most recent change of -$104.24 million (-14.70%) on June 30, 2023. Over the past year, it has dropped by -$834.56 million (-3917.76%).DICE TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DICE Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +110.0% | +52.4% | -3917.8% |
| 3 y3 years | +611.5% | +545.5% | -10000.0% |
| 5 y5 years | +611.5% | +545.5% | -10000.0% |
DICE Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | at high | -2640.6% |
DICE Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $11.30 M(+42.7%) | $32.01 M(+13.8%) |
| Mar 2023 | - | $7.91 M(+24.4%) | $28.13 M(+9.6%) |
| Dec 2022 | $25.66 M(+110.0%) | $6.36 M(-1.2%) | $25.66 M(+10.2%) |
| Sept 2022 | - | $6.44 M(-13.2%) | $23.30 M(+9.4%) |
| June 2022 | - | $7.41 M(+36.1%) | $21.30 M(+31.5%) |
| Mar 2022 | - | $5.45 M(+36.3%) | $16.20 M(+32.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $12.22 M(+144.2%) | $4.00 M(-10.1%) | $12.22 M(+29.8%) |
| Sept 2021 | - | $4.44 M(+91.8%) | $9.42 M(+40.1%) |
| June 2021 | - | $2.32 M(+58.2%) | $6.72 M(+52.6%) |
| Mar 2021 | - | $1.47 M(+23.0%) | $4.41 M(+49.8%) |
| Dec 2020 | $5.00 M(+38.7%) | $1.19 M(-31.9%) | $2.94 M(+68.1%) |
| Sept 2020 | - | $1.75 M | $1.75 M |
| Dec 2019 | $3.61 M | - | - |
FAQ
- What is DICE Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for DICE Therapeutics?
- What is DICE Therapeutics annual SG&A year-on-year change?
- What is DICE Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for DICE Therapeutics?
- What is DICE Therapeutics quarterly SG&A year-on-year change?
- What is DICE Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for DICE Therapeutics?
- What is DICE Therapeutics TTM SG&A year-on-year change?
What is DICE Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of DICE is $25.66 M
What is the all time high annual SG&A for DICE Therapeutics?
DICE Therapeutics all-time high annual selling, general & administrative expenses is $25.66 M
What is DICE Therapeutics annual SG&A year-on-year change?
Over the past year, DICE annual selling, general & administrative expenses has changed by +$13.44 M (+109.97%)
What is DICE Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of DICE is $11.30 M
What is the all time high quarterly SG&A for DICE Therapeutics?
DICE Therapeutics all-time high quarterly selling, general & administrative expenses is $11.30 M
What is DICE Therapeutics quarterly SG&A year-on-year change?
Over the past year, DICE quarterly selling, general & administrative expenses has changed by +$3.88 M (+52.36%)
What is DICE Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of DICE is -$813.26 M
What is the all time high TTM SG&A for DICE Therapeutics?
DICE Therapeutics all-time high TTM selling, general & administrative expenses is $32.01 M
What is DICE Therapeutics TTM SG&A year-on-year change?
Over the past year, DICE TTM selling, general & administrative expenses has changed by -$834.56 M (-3917.76%)